Antihyperglycaemic and hypolipidemic effect of methanol extracts of Ageratum conyzoides L (Asteraceae) in normal and diabetic rats

Purpose: To investigate the antihyperglycaemic and hypolipidemic potential of the methanol extracts of leaf, stem and root of Ageratum conyzoides in streptozotocin (STZ)-induced diabetic rats.Methods: The extract of each of the plant part was obtained by extraction in methanol. A total of 60 male Wistar albino rats (30 induced with diabetes and 30 normoglycaemic) were assigned into diabetic and normoglycaemic groups of 6 rats each. Methanol extracts of leaf, stem and root of Ageratum conyzoides were administered orally at a dose of 100 mg/kg to the rats for a period of 14 days, with glibenclamide as the standard drug (1 mg/kg). Fasting blood glucose and lipid profile were determined to ascertain the antihyperglycaemic and hypolipidemic activities of the different parts of the plant.Results: Ageratum conyzoides significantly (p < 0.05) reduced fasting blood glucose (FBG) levels in diabetic rats by 38.71 ± 19.41 % (leaf), 25.64 ± 20.53 % (stem), and 34.76 ± 18.03 % (root) on day 14 of the treatment, compared with untreated diabetic rats where FBG increased by 11.33±8.91 %. Total cholesterol (leaf, 119.10 ± 8.12 mg/dl; stem, 109.28 ± 8.13 mg/dl) and triglycerides (leaf, 61.71 ± 9.37 mg/dl; stem, 72.45 ± 3.39 mg/dl) levels were also significantly (p < 0.05) lowered in diabetic rats. Low density lipoprotein cholesterol (leaf, 77.21 ± 8.12 mg/dl; stem, 64.76 ± 8.04 mg/dl; root, 79.08 ± 10.61mg/dl) levels were significantly (p < 0.05) lowered in all treated diabetic groups compared with the untreated diabetic rats (103.19 ± 6.08 mg/dl).Conclusion: The results from this study indicate that Ageratum conyzoides has hypoglycaemic and hypolipidemic properties in rats, and this probably justifies its reported use in the traditional management of diabetes mellitus.Keywords: Ageratum conyzoides, Diabetes mellitus, Antihyperglycaemic, Hypolipidemi